Abstract
Recommendations for future research in leprosy include (i) cultivation of M. leprae in vitro; (ii) genetic control of susceptibility, including twin studies and HLA typing; (iii) precise antigenic analysis of M. leprae; (iv) mechanisms involved in the macrophage response to mycobacterial infections; (v) more use of experimental models such as normal mice infected with M. lepraemurium; (vi) reassessment of the protection afforded by BCG; (vii) assessment of protection afforded by killed (armadillo) M. leprae vaccine; (viii) pathogenesis of erythema nodosum leprosum including a study of the effect of thalidomide; and (ix) development of in vitro systems for drug sensitivity testing.
MeSH Terms
Animals
Antigens, Bacterial
Armadillos
BCG Vaccine/therapeutic use
Bacterial Vaccines/therapeutic use
Disease Models, Animal
Erythema Nodosum/immunology
HLA Antigens/analysis
Humans
Leprosy/drug therapy,immunology,prevention & control
Mice
Mycobacterium leprae/immunology,isolation & purification
Research
Chemicals
Antigens, Bacterial
BCG Vaccine
Bacterial Vaccines
HLA Antigens
References (15)
15 references, click to expand
-
In-vitro lymphoproliferative response to Mycobacterium leprae of HLA-D-identical siblings of lepromatous leprosy patients.
Lancet. 1978 Sep 9;2(8089):543-7
PMID: 79915
-
Antibodies against BCG antigen 60 in mycobacterial infection.
Br Med J. 1977 Aug 13;2(6084):430-3
PMID: 407965
-
Heat stability of Mycobacterium leprae immunogenicity.
Infect Immun. 1978 Oct;22(1):87-93
PMID: 365752
-
Autoradiographic and metabolic studies of Mycobacterium leprae.
Lepr Rev. 1978 Sep;49(3):187-98
PMID: 357867
-
Primary dapsone-resistant leprosy.
Lepr Rev. 1977 Jun;48(2):129-32
PMID: 330999
-
Airborne infection with Mycobacterium leprae in mice.
J Med Microbiol. 1977 Feb;10(1):63-8
PMID: 320339
-
Lymphocyte transformation test in leprosy; correlation of the response with inflammation of lesions.
Clin Exp Immunol. 1976 Jul;25(1):85-94
PMID: 791549
-
Immune complexes and complement hypercatabolism in patients with leprosy.
Clin Exp Immunol. 1976 Dec;26(3):388-96
PMID: 1009681
-
Ten years of dapsone in lepromatous leprosy: clinical, bacteriological and histological assessment and the finding of viable leprosy bacilli.
Lepr Rev. 1974 Dec;45(4):288-98
PMID: 4613977
-
The nasal dicharge in leprosy: clinical and bacteriological aspects.
Lepr Rev. 1974 Jun;45(2):121-34
PMID: 4608620
-
Immune responsiveness to Mycobacterium leprae and other mycobacterial antigens throughout the clinical and histopathological spectrum of leprosy.
Clin Exp Immunol. 1973 Aug;14(4):541-53
PMID: 4583777
-
Sulphone resistance in leprosy. A review of one hundred proven clinical cases.
Lancet. 1975 Jul 12;2(7924):69-72
PMID: 49662
-
Studies on the determination of the minimal inhibitory concentration of 4,4'-diamino-diphenyl-sulphone (Dapsone, DDS) against Mycobacterium leprae.
Lepr Rev. 1971 Jun;42(2):101-17
PMID: 4948480
-
Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
Int J Lepr Other Mycobact Dis. 1976 Jan-Jun;44(1-2):159-69
PMID: 776852
-
Classification of leprosy according to immunity. A five-group system.
Int J Lepr Other Mycobact Dis. 1966 Jul-Sep;34(3):255-73
PMID: 5950347